For thousands of British patients fighting the lobbying fight for legalization and for the millions of recreational users, the prospect of this ultra conservative nation making change is somewhere off in the distant horizon.
In a country where public and political conversation is stuck, caught in the dual headlights of ‘Skunk’ and ‘Synthetic Cannabis’ the future of regulatory reform would seem to anyone, a far-flung dream unlikely to become reality.
In this article, we’ll take you through 5 reason we believe the UK has not just been overlooked but could be the dark horse that dominates parts of the industry.
Founded in the UK in 2008, GWPharma is one of the oldest and companies in the industry. Whilst not mainstream, the British pharmaceutical industry together with the London financial markets have validated cannabis businesses.
- Health & Wellness
In a recent report by Frost & Sullivan entitled “Global Nutraceutical Industry: Investing in Healthy Living” they concluded about the UK: The UK has emerged as a key test market for nutraceuticals, resulting in a high frequency of product launches. In a country with no medical cannabis program insight, CBD is emerging from this food supplement sector.
It’s the start-up nation and the historic homeland of medical cannabis research. Trade relationships between these two countries are strong, specifically when focused on health. The mission of CiiTECH is to bring sophisticated CBD products to the UK based on our proprietary cannabis research conducted in Israel.
We’re all sick of it, but we have another 18 months until it happens, and then depending on ‘The Deal’ a bunch more either lamenting or celebrating. One thing is for sure, a Tory managed BREXIT will result in strong independent Britain as a global trading partner.
The heart of the matter, the issue that without resolution none else matter. The UK legal position has been clear for many years, cannabis is a dangerous psychoactive narcotic that must be scheduled, controlled and kept off the streets and away from the weak and the meak. Whilst not untrue, this is but one layer of the complex story as CBD is being considered as a food / dietary supplement.
Is the UK a dark horse that as the market matures finds itself quietly creeping up on the pacesetters? In a normal world, the answer is simple, in 2017 who knows?